Contribution of the Transcription Factors Sp1/Sp3 and AP-1 to Clusterin Gene Expression during Corneal Wound Healing of Tissue-Engineered Human Corneas
Open Access
- 17 November 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (22) , 12426
Abstract
In order to reduce the need for donor corneas, understanding of corneal wound healing and development of an entirely tissue-engineered human cornea (hTECs) is of prime importance. In this study, we exploited the hTEC to determine how deep wound healing affects the transcriptional pattern of corneal epithelial cells through microarray analyses. We demonstrated that the gene encoding clusterin (CLU) has its expression dramatically repressed during closure of hTEC wounds. Western blot analyses confirmed a strong reduction in the expression of the clusterin isoforms after corneal damage and suggest that repression of CLU gene expression might be a prerequisite to hTEC wound closure. Transfection with segments from the human CLU gene promoter revealed the presence of three regulatory regions: a basal promoter and two more distal negative regulatory regions. The basal promoter bears DNA binding sites for very potent transcription factors (TFs): Activator Protein-1 (AP-1) and Specificity protein-1 and 3 (Sp1/Sp3). By exploiting electrophoretic mobility shift assays (EMSA), we demonstrated that AP-1 and Sp1/Sp3 have their DNA binding site overlapping with one another in the basal promoter of the CLU gene in hCECs. Interestingly, expression of both these TFs is reduced (at the protein level) during hTEC wound healing, thereby contributing to the extinction of CLU gene expression during that process. The results of this study contribute to a better understanding of the molecular mechanisms accounting for the repression of CLU gene expression during corneal wound healing.Keywords
Funding Information
- Canadian Institutes of Health Research (FDN-143213)
This publication has 101 references indexed in Scilit:
- Non-Secreted Clusterin Isoforms Are Translated in Rare Amounts from Distinct Human mRNA Variants and Do Not Affect Bax-Mediated Apoptosis or the NF-κB Signaling PathwayPLOS ONE, 2013
- Interaction of Clusterin and Matrix Metalloproteinase-9 and Its Implication for Epithelial Homeostasis and InflammationThe American Journal of Pathology, 2012
- Clusterin Attenuates the Development of Renal FibrosisJournal of the American Society of Nephrology, 2012
- AP-1 Regulates Cyclin D1 and c-MYC Transcription in an AKT-Dependent Manner in Response to mTOR Inhibition: Role of AIP4/Itch-Mediated JUNB DegradationMolecular Cancer Research, 2011
- The coactivator CRTC1 promotes cell proliferation and transformation via AP-1Proceedings of the National Academy of Sciences, 2009
- Differential Binding of the Transcription Factors Sp1, AP-1, and NFI to the Promoter of the Human α5 Integrin Gene Dictates Its Transcriptional ActivityInvestigative Ophthalmology & Visual Science, 2009
- Increased Clusterin Expression in Fuchs’ Endothelial DystrophyInvestigative Ophthalmology & Visual Science, 2008
- c-Jun Homodimers Can Function as a Context-Specific CoactivatorMolecular and Cellular Biology, 2007
- Regulation of poly(ADP-ribose) polymerase-1 (PARP-1) gene expression through the post-translational modification of Sp1: a nuclear target protein of PARP-1BMC Molecular Biology, 2007
- An Improved CAT Assay for Promoter Analysis in Either Transgenic Mice or Tissue Culture CellsDNA and Cell Biology, 1992